高级检索
当前位置: 首页 > 详情页

Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665- HMGB1 axis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Tumor Immunotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China [2]Department of General Surgery, Third Hospital of Shijiazhuang, Shijiazhuang, China [3]Department of General Surgery, Second Hospital of Hebei Medical University, Shijiazhuang, China [4]International Cooperation Laboratory of Stem Cell Research, Hebei Medical University, Shijiazhuang, China
出处:
ISSN:

关键词: Gastric cancer hsa_circ_0006646 miR-665 high mobility group box 1 ( HMGB1 ) epithelial- epithelial- mesenchymal transition (EMT)

摘要:
Background: Mounting evidences indicate that circular RNAs (circRNAs) are a novel class of noncoding RNAs and play vital roles in the tumorigenesis and aggressiveness including gastric cancer (GC). Nevertheless, the precise functions and underlying mechanisms of circRNAs in GC remain largely unknown. Methods: The Gene Expression Omnibus (GEO) data set GSE163416 was analyzed to screen the key circRNAs in GC. hsa_circ_0006646 was chosen for further study. GC tissues and matched adjacent normal gastric mucosal epithelial tissues were obtained from the Fourth Hospital of Hebei Medical University. The expressions of hsa_circ_0006646 was detected using quantitative real-time polymerase chain reaction (qRT-PCR). hsa_circ_0006646 was knocked down to identify its effects on GC cells. Bioinformatics algorithms were analyzed to predict the microRNA (miRNAs) potentially sponged by hsa_circ_0006646 and its target genes. Fluorescence in situ hybridization (FISH) was conducted to determine the subcellular location of hsa_circ_0006646 and the predicted miRNA. Then, qRT-PCR, luciferase reporter assay, radioimmunoprecipitation assay, Western blotting, and miRNA rescue experiments were used to confirm the hsa_circ_0006646-related regulatory axis in GC. Cell Counting Kit-8 (CCK-8), colony formation, wound healing, and Transwell experiments were performed to determine the effect of the hsa_circ_0006646-related regulatory axis on GC cells' malignant behaviors in vitro. The xenograft tumor mouse model was established to evaluate the effect of hsa_circ_0006646 in vivo. Results: hsa_circ_0006646 exhibited a high expression in GC tissues as compared to corresponding adjacent normal gastric mucosal epithelial tissues and its high expression was positively correlated with TNM stage, lymph node invasion and poor prognosis (P<0.05). Knockdown of hsa_circ_0006646 suppressed the proliferation, colony formation, migration, and invasion in GC cells (all P<0.05). hsa_circ_0006646 upregulated high mobility group box 1 (HMGB1) by sponging miR-665 in GC cells (P<0.05). The hsa_ circ_0006646-miR-665-HMGB1 axis promoted malignant behaviors and epithelial-mesenchymal transition (EMT) in GC cells by activating the Wnt/beta-catenin pathway (P<0.05). The existence of hsa_circ_0006646-miR-665-HMGB 1 axis was confirmed in GC specimens (P<0.05). Consequently, down-regulated hsa_ circ_0006646 inhibited the progression and EMT of GC cells in vivo (P<0.05). Conclusions: For the first time, we demonstrated that hsa_circ_0006646-miR-665-HMGB1 axis exerted its tumor-promoting effects in GC, which suggested that hsa_circ_0006646 could be potentially targeted for GC treatment.

基金:

基金编号: 81871894 91942314 H2021206070

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 肿瘤学
JCR分区:
出版当年[2023]版:
Q3 GASTROENTEROLOGY & HEPATOLOGY Q3 ONCOLOGY
最新[2023]版:
Q3 GASTROENTEROLOGY & HEPATOLOGY Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Department of Tumor Immunotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China [2]Department of General Surgery, Third Hospital of Shijiazhuang, Shijiazhuang, China
通讯作者:
通讯机构: [1]Department of Tumor Immunotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China [3]Department of General Surgery, Second Hospital of Hebei Medical University, Shijiazhuang, China [4]International Cooperation Laboratory of Stem Cell Research, Hebei Medical University, Shijiazhuang, China [*1]Department of General Surgery, Second Hospital of Hebei Medical University, 215 Heping West Road,Xinhua District, Shijiazhuang 050004, China [*2]Department of Tumor Immunotherapy, Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Yuhua District, Shijiazhuang 050035, China.International Cooperation Laboratory of Stem Cell Research, Hebei Medical University, Shijiazhuang, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号